Use of trimethoprim-sulfamethoxazole to prevent bacterial infections in children with acute lymphoblastic leukemia

Pediatric Infectious Disease

Volumn 4, Issue 3, 1985, Pages 265-269

  Goorin, Allen M ^a   Hershey, Brenda J ^a,b   Levin, Myron J ^c   Siber, George R ^a   Gelber, Richard D ^a   Flynn, Kerrie ^d   Lew, Michael ^a   Beckett, Kevin ^a   Blanding, Peter ^a   Sallan, Stephen E ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b Hexcel Medical ^*  (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; PLACEBO;

ACUTE LYMPHOBLASTIC LEUKEMIA; BACTERIAL INFECTION; BLOOD AND HEMOPOIETIC SYSTEM; CANCER COMBINATION CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDICATION; DRUG THERAPY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYMPHATIC SYSTEM; METHODOLOGY; ORAL DRUG ADMINISTRATION; PREVENTION; PRIORITY JOURNAL; PROPHYLAXIS; THERAPY;

ADMINISTRATION, ORAL; ADOLESCENT; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC; MALE; RANDOM ALLOCATION; SULFAMETHOXAZOLE; SUSPENSIONS; TRIMETHOPRIM; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0021916750     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-198505000-00012     Document Type: Article

References (14)

1. Hughes WT, Kuhn S, Chaudhar S, Feldman S, et al: Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med 297:1419-1426, 1977
2. Sallan SE, Hitchcock-Bryan S, Gelber R, et al: Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia. Cancer Res 43:5601-5607, 1983
3. Schwartz DE, Kolchlin BA, Weinfeld RE: Fluorometric analysis of trimethoprim in serum. Chemotherapy 14 (suppl): 22-29, 1969
4. Bratton AC, Marshall EK, Baggitt D, et al: Colourimetric quantitation of sulfa containing compounds. J Biol Chem 128:537, 1939
5. Armitage P: Sequential Medical Trials. New York, John Wiley and Son, Inc., 1975, pp 48-70
6. Lehmann EL: Testing Statistical Hypothesis. New York, John Wiley, and Son, Inc., 1959, pp 140-142
7. Enno A, Darrell J, Hows J, et al: Co-trimoxazole for prevention of infections in acute leukaemia. Lancet 2:395-397, 1978
8. Gurwith MJ, Brunton JL, Lank BA, et al: A prospective controlled investigation of prophylactic trimethoprim/sulfameth-oxazole in hospitalized granulocytopenic patients. Am J Med 66:248-255, 1979
9. Dekker AW, Rozenberg-Arska M, Sixma DA, et al: Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute non-lymphocytic leukemia. Ann Intern Med 95:555-559, 1981
10. Wade JC, Schimpff SC, Hargadon MS, et al: A comparison of trimethoprim-sulfamethoxazole plus nystatin with gentamicin plus nystatin in the prevention of infections in acute leukemia. N Engl J Med 304:1057-1062, 1981
11. Weiser B, Lange M, Failk M, et al: Prophylactic trimethoprim-sulfamethoxazole during consolidation chemotherapy for acute leukemia: A controlled trial. Ann Intern Med 95:436-438, 1981
12. Starke SD, Catovsky D, Johnson SA, et al: Co-trimoxazole alone for prevention of bacterial infection in patients with acute leukaemia. Lancet 1:5-6, 1982
13. Watson JG, Powles RL, Lawson DN, et al: Co-trimoxazole versus non-absorbable antibiotics in acute leukemia. Lancet 1:6-7, 1982
14. Wilson J, Guiney D: Failure of oral trimethoprim-sulfameth-oxazole prophylaxis in acute leukemia. N Engl J Med 306:16-19, 1982